• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    23.00 Up 0.81(3.65%) Jan 29, 4:00PM EST
    |After Hours : 23.00 0.00 (0.00%) Jan 29, 4:41PM EST
    Add to Portfolio
    Prev Close:22.19
    Open:22.30
    Bid:21.50 x 200
    Ask:N/A
    1y Target Est:7.35
    Beta:1.71
    Next Earnings Date:N/A
    Day's Range:22.00 - 23.05
    52wk Range:12.38 - 24.46
    Volume:85,982
    Avg Vol (3m):177,957
    Market Cap:764.91M
    P/E (ttm):N/A
    EPS (ttm):-3.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jan-13) :N/A
    Quarterly EPS Est (Jul-12) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback